2014
DOI: 10.1074/jbc.m114.576934
|View full text |Cite
|
Sign up to set email alerts
|

Pyruvate Kinase M2 in Blood Circulation Facilitates Tumor Growth by Promoting Angiogenesis

Abstract: Background: It is known that PKM2 is present in cancer patient blood. It is not known if PKM2 functions in cancer progression. Results: PKM2 in blood facilitates tumor growth by promoting tumor angiogenesis via increasing angiogenic endothelial cell migration and ECM attachment. Conclusion: Extracellular PKM2 promotes tumor angiogenesis. Significance: We reveal a novel mechanism of cancer angiogenesis that could potentially be a new target for anti-angiogenesis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
73
1
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 74 publications
(80 citation statements)
references
References 21 publications
4
73
1
2
Order By: Relevance
“…Our previous study demonstrated that extracellular PKM2 facilitates tumor growth by promoting angiogenesis. The extracellular PKM2 promotes angiogenesis by facilitating endothelial cell migration and extracellular matrix (ECM) attachment . High serum levels of PKM2 are also detected in patients of various inflammatory diseases, indicating a potential association of release of extracellular PKM2 with inflammations.…”
mentioning
confidence: 99%
“…Our previous study demonstrated that extracellular PKM2 facilitates tumor growth by promoting angiogenesis. The extracellular PKM2 promotes angiogenesis by facilitating endothelial cell migration and extracellular matrix (ECM) attachment . High serum levels of PKM2 are also detected in patients of various inflammatory diseases, indicating a potential association of release of extracellular PKM2 with inflammations.…”
mentioning
confidence: 99%
“…Recombinant pyruvate kinase M2 (rPKM2) was produced by Dr. Zhi-Ren Liu's group according to the published protocol [20,21]. rPKM2 (160 ng/kg) was administered intranasally according to established procedures every other day starting 24 h after stroke until the animals were sacrificed [22].…”
Section: Drug Administrationmentioning
confidence: 99%
“…PKM2 can regulate gene transcription MEK5 by phosphorylating STAT3, which in turn activates numerous transcriptional factors to regulate cell proliferation, differentiation, migration, and survival [11,12,19]. PKM2 greatly promotes tumorous angiogenesis through enhancing the endothelial cell migration and extracellular matrix attachment [20]. PKM2 was recently found to be released by neutrophils at peripheral wound sites and to facilitate early wound healing by promoting angiogenesis [21].…”
Section: Introductionmentioning
confidence: 99%
“…26,27,33,34 Specifically PKM2, which is the rate-limiting enzyme of glycolysis, controlling the conversion of phosphoenolpyruvate to pyruvate, has recently been shown to promote angiogenesis in ECs. 24,25 Indeed, we found that knockdown of PKM2 resulting in impaired angiogenic sprouting and JMJD8 stimulates the formation of pyruvate in ECs. The precise mechanism of how JMJD8 regulates PKM2 is currently unknown.…”
Section: Discussionmentioning
confidence: 92%
“…However, N-terminal deletion of aa 1 to 200 of JMJD8 (Δ2 construct) did prevent binding to PKM2 ( Figure IVA and IVB in the online-only Data Supplement), suggesting that PKM2 interaction with JMJD8 occurs in the region between aa 63 and 124. Interestingly, PKM2 has recently been shown to promote angiogenesis in ECs, 24,25 suggesting that cytoplasmic JMJD8 could regulate angiogenesis by controlling metabolic functions of EC, a mechanism which was recently shown to play a key role in regulating angiogenesis. 26,27 …”
Section: Jmjd8 Has An Extranuclear Localization and Binds To Pkm2 In Ecsmentioning
confidence: 99%